Overview
A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
Status:
Completed
Completed
Trial end date:
2010-10-04
2010-10-04
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will assess, over a 4-week treatment period, the safety and efficacy of the addition of sitagliptin to metformin in participants with type 2 diabetes mellitus (T2DM) who failed to achieve glycemic control on metformin monotherapy.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Metformin
Sitagliptin Phosphate
Criteria
Inclusion Criteria:- Participants with T2DM failing metformin monotherapy
- Between the ages of 18 and 79
Exclusion Criteria:
- Participants has a history of type 1 Diabetes Mellitus or ketoacidosis